OP-ED: What Could We Do if GLP-1 Weight Loss Drugs Were Free? Would Our Obesity Epidemic Be Solved for Good?
ACHP President and CEO Ceci Connolly coauthored an op-ed examining if the obesity epidemic could be solved with free GLP-1s.
ACHP President and CEO Ceci Connolly coauthored an op-ed examining if the obesity epidemic could be solved with free GLP-1s.
ACHP member HealthPartners has outlined strategies to reduce hypertension in its community as part of the Chronic Disease Pledge.
The Helmsley Charitable Trust awarded a $1.5M grant to ACHP to support its Chronic Disease Pledge to improve diabetes outcomes by 2030.
This Chronic Disease Day, ACHP’s Dr. Jennifer Lee highlights the Chronic Disease Pledge ACHP member companies have taken to address chronic diseases in their communities.
ACHP member organizations are committed to preventing and managing chronic disease – focusing on diabetes and hypertension – in communities across the nation.
ACHP is the voice of a unique approach in health care today, one that puts the patient at the center with plans and clinical teams collaborating to improve health outcomes and reduce costs. Our advocacy focuses on providing policymakers with tested solutions, rooted in a model that is proven to deliver better value for patients, employers and taxpayers.